Harvoni Cost: How to Pay $0 Instead of $94,500

Harvoni cost in the United States starts at a list price of about $94,500 for a full 12-week course — but that wholesale figure is almost never what a patient actually pays. Harvoni (ledipasvir/sofosbuvir) is a direct-acting antiviral that cures most hepatitis C infections, and between insurance, Medicaid, an authorized generic, and Gilead’s assistance programs, most eligible patients reach $0 or close to it. This SunnyPharma guide breaks down every price you might see and the fastest path to affordable treatment.

What Harvoni costs at list price

Harvoni’s wholesale acquisition cost is about $1,125 per tablet, or roughly $94,500 for a standard 12-week course. That list price comes from Gilead’s published manufacturer pricing and is independently confirmed by the Fair Pricing Coalition. The standard regimen is one tablet daily; most patients take it for 12 weeks (84 tablets), though some take 8 weeks (about $63,000 at list) and a few take 24 weeks.

Wholesale acquisition cost (WAC) is the manufacturer’s published list price to wholesalers, before any rebates, insurer discounts, or assistance. It is a contracting benchmark — not the number that lands on a patient’s bill. Nearly every pathway below brings the real cost far below list.

Your clinician determines course length. Patients should not self-select duration.

“Hepatitis C is curable, and in my practice almost no one pays the list price. Cost should never be why someone goes untreated — ask for help, and take it.”

— Dr. Ranjit Mohan, MBBS, MD, Infectious Disease physician

Harvoni cost without insurance

Without insurance, the brand list price is about $94,500 per course — but uninsured patients have two much cheaper routes. First, the Gilead Support Path Patient Assistance Program provides Harvoni free to eligible, qualified uninsured patients. Second, the authorized generic (below) carries a lower list price. Uninsured and cash-paying patients are not eligible for Gilead’s copay coupon, so the Patient Assistance Program is the pathway to focus on.

To apply, call Support Path at 1-855-769-7284 (Monday–Friday, 9 a.m.–8 p.m. ET). If you are recently uninsured or between jobs, also check Medicaid eligibility in your state — it covers hepatitis C treatment in all 50 states.

The authorized generic: ledipasvir/sofosbuvir

An authorized generic version of Harvoni, ledipasvir/sofosbuvir, has a list price of about $12,000 per 28-tablet bottle — roughly $36,000 for a 12-week course, well below brand Harvoni. It is made by Asegua Therapeutics, a Gilead subsidiary, and is the same medicine as brand Harvoni, FDA-approved for U.S. dispensing. Because it is an authorized generic rather than a competitive patent-cliff generic, its price sits below brand but does not collapse the way some generics do.

Retail cash prices with pharmacy discount cards are often reported lower than the list figure. Commercially insured patients who use the generic can enroll in a separate copay program at aseguacopay.com. Ask your prescriber whether the generic is appropriate for you — for most patients it is clinically identical.

Harvoni cost with insurance

With commercial insurance, what you pay depends on your plan’s specialty-tier design, deductible, and coinsurance — and Gilead’s copay coupon can lower it substantially. Harvoni is usually a specialty-tier medication, which can mean coinsurance rather than a flat copay. The Support Path copay coupon, for eligible commercially insured patients, covers up to 25% of the catalog price for three bottles over six months, with no monthly limit.

Important: the copay coupon applies only to commercial insurance. It does not apply to Medicare Part D, Medicaid, TRICARE, VA, or other government coverage. Patients with those programs should use Medicaid coverage, Medicare assistance, or nonprofit foundations instead.

How to get Harvoni for $0

Most patients can reach little or no cost by matching their situation to the right program. The pathways below are ordered by how most people qualify. Do not delay treatment while you sort out cost — hepatitis C is curable, and assistance can usually be arranged quickly.

Does Medicaid cover Harvoni?

Yes — Medicaid covers hepatitis C direct-acting antivirals, including Harvoni and its generic, in all 50 states. Most states have removed the older sobriety and liver-damage restrictions that once delayed treatment, so more patients can be treated earlier. If you have Medicaid, your out-of-pocket cost for Harvoni is typically minimal.

Coverage details, preferred products, and prior-authorization steps vary by state. Ask your prescriber or clinic to confirm your state’s rules and to submit any required paperwork. If you are unsure whether you qualify for Medicaid, your clinic’s financial counselor or a Ryan White–style program can help you check.

What about buying Harvoni in Mexico?

Some U.S. patients look across the border for lower prices, but most people can reach $0 to low cost inside the United States first. Between Medicaid, Gilead’s Support Path, and the authorized generic, the U.S. pathways above resolve cost for the large majority of patients — without the uncertainty of sourcing medication abroad.

If you are still weighing cross-border options, our companion guide covers what can and cannot be verified about Mexican pharmacy pricing and access.

Harvoni cost: frequently asked questions